We hypothesize that individuals who develop strong self-reactions against IFN-α might experience a milder form of AD as this autoimmunity could potentially reduce β-cell exposure to immune-mediated cytotoxicity and subsequent cell death. Here, IFNA2 is linked to Alzheimer disease.